Improved Metabolic Health: It has been shown to improve insulin sensitivity, reduce blood sugar levels, and lower HbA1c, making it beneficial for individuals with type 2 diabetes or prediabetes
The most appropriate treatment depends on factors including: medical history BMI weight-related health risks previous treatment response current medication personal preferences potential side effects clinical eligibility Semaglutide is injected under the skin rather than into a muscle or vein
He said: It is well established that better mental health tends to follow from better physical health and since the 1880s we have known that diabetes is associated with depression, although I think its unlikely that using GLP-1R agonists alone as treatments for depression or anxiety will work. Prof Eduard Vieta, a professor of psychiatry at the University of Barcelona and editor in chief of the European College of Neuropsychopharmacology journal, said: From a clinical perspective, these findings are reassuring regarding the psychiatric safety of GLP-1 receptor agonists and suggest a potential role not only in preventing worsening but also, possibly, in improving mental health outcomes
Novo Nordisk A/Ss weight-loss and diabetes drugs are no longer in short supply, U.S
